Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TREMELIMUMAB vs TREOSULFAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TREMELIMUMAB vs TREOSULFAN: Safety Overview

Metric TREMELIMUMAB TREOSULFAN
Total FAERS Reports 2,387 1,711
Deaths Reported 594 322
Death Rate 24.9% 18.8%
Hospitalizations 1,510 279
Average Patient Age 64.7 yrs 15.9 yrs
% Female Patients 31.6% 46.3%
FDA Approval Date N/A Jan 21, 2025
Manufacturer AstraZeneca Pharmaceuticals LP Medexus Pharma, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status N/A Prescription